Decent across the board but slightly lower org. top line makes us lower our '24e organic growth assumptions by 2pp. Limited total revisions on better FX - keep BUY at 21x '25e EV/EBIT.
Underlying top-line growth is accelerating, +25% y-o-y Opex up 11% q-o-q main concern, but GM slightly better Retain HOLD as we still await a better entry point